ESSA Pharma seeks court approval for $1.91/share cash distribution and special meeting on Aug 5

ESSA Pharma Inc.

Intends to apply to Supreme Court of BC on August 5, 2025 for interim order and cash distribution order.
Estimated total consideration per share ~US$1.91, including initial cash distribution and closing cash, plus CVRs.
Cash distribution seeks to expedite payout to shareholders prior to closing of XenoTherapeutics acquisition.
Hearing set for 9:45 a.m. PT on August 5, 2025 in Vancouver; response materials due by July 31.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.